Nucleoside reverse transcriptase inhibitors (NRTIs)

LOGO Wellcome Y9C 100 Pill - blue & white capsule-shape, 16mm

Generic Name: zidovudine

Pill with imprint LOGO Wellcome Y9C 100 is Blue & White, Capsule-shape and has been identified as Retrovir 100 mg. It is supplied by GlaxoSmithKline.

Retrovir is used in the treatment of HIV Infection; Occupational Exposure; Nonoccupational Exposure; Reduction of Perinatal Transmission of HIV and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Retrovir 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Retrovir (oral/injection) (Zidovudine (oral/injection) [ zye-doe-vyoo-deen ])-LOGO Wellcome Y9C 100-100 mg-Blue & White-Capsule-shape
Retrovir (oral/injection) (Zidovudine (oral/injection) [ zye-doe-vyoo-deen ])-LOGO Wellcome Y9C 100-100 mg-Blue & White-Capsule-shape
Retrovir (oral/injection) (Zidovudine (oral/injection) [ zye-doe-vyoo-deen ])-LOGO Wellcome Y9C 100-100 mg-Blue & White-Capsule-shape
Retrovir (oral/injection) (Zidovudine (oral/injection) [ zye-doe-vyoo-deen ])-LOGO Wellcome Y9C 100-100 mg-Blue & White-Capsule-shape

Retrovir (oral/injection)
Generic Name: zidovudine (oral/injection) [ zye-doe-vyoo-deen ]
Imprint: LOGO Wellcome Y9C 100
Strength: 100 mg
Color: Blue & White
Size: 16.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00173-0108 (Discontinued)
Inactive Ingredients:
Latest News
Related Drugs